Clinical tests on persons with severe heart disease have shown that when their own stem cells were injected back into their hearts, their heart disease showed marked improvement. These heart patients regained some of the mobility they had lost as a result of their heart disease and saw a reversal of some of their symptoms.
The tests were conducted by heart researchers from Northwestern University and used a device developed by Baxter International, Inc. The device extracts stem cells from the patients’ bone marrow and purifies them for re-introduction into the donors’ hearts.The test panel consisted of 167 males divided into a test and a control group. All of the men suffered from medium to severe heart disease. The test just completed Phase II of a three-part series, and after the second phase, many in the test group patients had already seen a reduction in angina and an increase in their mobility. Some of the patients had angioplasty at some point in their pasts, or even had open-heart surgery. After they had taken the stem cell treatments, many formerly home-bound heart patients could resume nearly normal activities like going grocery shopping or climbing stairs.
These test results have created a lot of interest and even excitement within their respective medical circles. They were presented to the American Heart Association at their scientific conference in Orlando, Florida, this past fall. The third phase is the last one needed to receive FDA approval, but the date for its launch has not yet been set. The third and last phase of testing will involve a larger sample.
This is not a precedent as there are similar examples of introducing the patients’ own stem cells into their diseased bodies that help cure their diseases. One disease with similar results is cancer therapy, particularly lymphatic cancer.There has also been some remarkable improvement in persons suffering from spinal cord injuries.